XBiotech (XBIT) Short term Debt (2024)
XBiotech (XBIT) reported Short term Debt of $10.25 million for Q4 2024, up 2.5% from the prior quarter.
Powered by 
Analysis
XBiotech (XBIT) Short term Debt (2024) Analysis & Trends
Dating back to Q1 2024, XBiotech's Short term Debt record includes 4 quarters.
- Per Business Quant data, the three quarters before Q4 2024 came in at $10 million (Q3 2024), $10 million (Q2 2024) and $10 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,156.48 Bn | 1,125.07 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.52 Bn | 542.04 Bn | 17.26 Bn |
| 3 | AbbVie | 511.52 Bn | 484.64 Bn | 12.70 Bn |
| 4 | Merck | 366.08 Bn | 320.46 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.10 Bn | 261.09 Bn | 11.24 Bn |
| 6 | Astrazeneca | 260.97 Bn | 234.66 Bn | 12.86 Bn |
| 7 | Amgen | 234.36 Bn | 189.76 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.20 Bn | 167.40 Bn | 6.22 Bn |
| 9 | Pfizer | 171.61 Bn | 118.26 Bn | 10.94 Bn |
| 10 | XBiotech | 61.28 Mn | -474.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 10.25 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |
API Access
XBiotech Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();